Michael W DepasqualeDirector · Chief Executive Officer · Chairman
4
Filed Nov 19, 2026Period of report Nov 17, 20260001437749-26-037627
| Transaction | Security | Shares | Price | ValueValue (shares × price) | Held after | Ownership |
|---|---|---|---|---|---|---|
PurchaseNov 17, 2026 | Common StockF1 | 1,986 | $1.91 | $3.79K | 12,764 | Direct |
Filing footnotes · 1
- F1Holdings do not include options to purchase 24 shares and 917 shares issuable upon exercise of warrants. All share amounts reflect BIO-key's 1-for-10 reverse stock split, which was effective April 30, 2026.